Video | 15 February 2020 A recipe for an affordable medicine goes bad 1 min RESEARCH AND DEVELOPMENT Governments use taxpayer money to try to get Big Pharma to develop medicines we need. These incentives are supposed to be the ingredients for an affordable medicine. Watch the video to see how it really turns out. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Statement | 30 January 2015 Research and development 136th WHO EB - MSF intervention on CEWG R&D Financing and Coordination Feature story Feature story | 18 December 2014 Research and development European Union Protecting Generic Medicines in Transit Through the EU Feature story | 08 December 2014 Research and development Congress should fix the priority review voucher program: MSF’s Rius explains 6 min Statement | 17 November 2014 Research and development R&D cost estimates - MSF response to Tufts CSDD study on cost to develop a new drug Statement | 16 October 2014 Research and development Vaccines MSF responds to GSK remarks on Ebola vaccine Opinion article | 02 October 2014 Research and development Why We Need Open Source Pharma 4 min Statement | 22 May 2014 Research and development MSF intervention on the report of the CEWG on R&D at 67th WHA Statement | 31 January 2014 Research and development MSF responds to news of pull out of neglected disease R&D by AstraZeneca 2 min Load More
Statement | 30 January 2015 Research and development 136th WHO EB - MSF intervention on CEWG R&D Financing and Coordination
Feature story Feature story | 18 December 2014 Research and development European Union Protecting Generic Medicines in Transit Through the EU
Feature story | 08 December 2014 Research and development Congress should fix the priority review voucher program: MSF’s Rius explains 6 min
Statement | 17 November 2014 Research and development R&D cost estimates - MSF response to Tufts CSDD study on cost to develop a new drug
Statement | 16 October 2014 Research and development Vaccines MSF responds to GSK remarks on Ebola vaccine
Statement | 22 May 2014 Research and development MSF intervention on the report of the CEWG on R&D at 67th WHA
Statement | 31 January 2014 Research and development MSF responds to news of pull out of neglected disease R&D by AstraZeneca 2 min
